Status:
COMPLETED
US 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1 Emphysema Study - Initial Formulation
Lead Sponsor:
Aeris Therapeutics
Conditions:
Pulmonary Emphysema
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine whether the Aeris Bronchoscopic Lung Volume Reduction (BLVR) System is safe in patients with advanced emphysema.
Detailed Description
Patients with emphysema currently have limited treatment choices. Many patients are treated with steroids and inhaled medications, which often provide little or no benefit. Recently, lung volume reduc...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Advanced emphysema
- Limited exercise capacity and persistent symptoms despite medical therapy
- Age between 18 and 75
- No significant heart, kidney or liver disease
- Willingness and ability to tolerate bronchoscopy
- No prior Lung Volume Reduction Surgery or Lung Transplantation
- Screening test results indicating that the procedure is appropriate
Exclusion
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT00085852
Start Date
April 1 2005
End Date
June 1 2007
Last Update
March 6 2008
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115
2
Caritas St Elizabeth's Medical Center
Boston, Massachusetts, United States, 02135